Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb 8;55(2):185-187.
doi: 10.1016/j.immuni.2022.01.005. Epub 2022 Jan 19.

Are NKT cells a useful predictor of COVID-19 severity?

Hui-Fern Koay  1 , Nicholas A Gherardin  2 , Thi H O Nguyen  2 , Wuji Zhang  2 , Jennifer R Habel  2 , Rebecca Seneviratna  2 , Fiona James  3 , Natasha E Holmes  4 , Olivia C Smibert  5 , Claire L Gordon  6 , Jason A Trubiano  7 , Katherine Kedzierska  2 , Dale I Godfrey  8
Affiliations
Comment

Are NKT cells a useful predictor of COVID-19 severity?

Hui-Fern Koay et al. Immunity. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests D.I.G. and N.A.G. have a provisional patent application submitted that describes immunotherapy and vaccine approaches for COVID-19. All other authors declare no competing interests.

Comment in

Comment on

  • Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.
    Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Kreutmair S, et al. Immunity. 2021 Jul 13;54(7):1578-1593.e5. doi: 10.1016/j.immuni.2021.05.002. Epub 2021 May 9. Immunity. 2021. PMID: 34051147 Free PMC article.

References

    1. Godfrey D.I., Uldrich A.P., McCluskey J., Rossjohn J., Moody D.B. The burgeoning family of unconventional T cells. Nat. Immunol. 2015;16:1114–1123. - PubMed
    1. Jouan Y., Guillon A., Gonzalez L., Perez Y., Boisseau C., Ehrmann S., Ferreira M., Daix T., Jeannet R., François B., et al. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients. J. Exp. Med. 2020;217:e20200872. - PMC - PubMed
    1. Kreutmair S., Unger S., Núñez N.G., Ingelfinger F., Alberti C., De Feo D., Krishnarajah S., Kauffmann M., Friebel E., Babaei S., et al. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021;54:1578–1593.e5. - PMC - PubMed
    1. Le Dieu R., Taussig D., MacDougal F., Lister A., Gribben J.G. CD3+/CD56+ Cells, but Not Natural Killer T Cells, Are Increased in Peripheral Blood of Untreated Patients with Leukemia. Blood. 2007;110 1815–1815.
    1. Lee P.T., Putnam A., Benlagha K., Teyton L., Gottlieb P.A., Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002;110:793–800. - PMC - PubMed